Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Applied DNA Sciences stock price, quote, forecast and news

APDN
US03815U3005
A2PUTA

Price

1.45
Today +/-
+0.13
Today %
+10.14 %
P

Applied DNA Sciences stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Applied DNA Sciences stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Applied DNA Sciences stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Applied DNA Sciences stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Applied DNA Sciences's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Applied DNA Sciences Stock Price History

DateApplied DNA Sciences Price
9/6/20241.45 undefined
9/5/20241.31 undefined
9/4/20241.20 undefined
9/3/20241.52 undefined
8/30/20241.91 undefined
8/29/20242.21 undefined
8/28/20242.42 undefined
8/27/20242.39 undefined
8/26/20242.20 undefined
8/23/20242.54 undefined
8/22/20241.83 undefined
8/21/20242.07 undefined
8/20/20241.54 undefined
8/19/20241.79 undefined
8/16/20240.78 undefined
8/15/20240.44 undefined
8/14/20240.45 undefined
8/13/20240.35 undefined
8/12/20240.36 undefined
8/9/20240.36 undefined

Applied DNA Sciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Applied DNA Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Applied DNA Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Applied DNA Sciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Applied DNA Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Applied DNA Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Applied DNA Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Applied DNA Sciences’s growth potential.

Applied DNA Sciences Revenue, EBIT and net profit per share

DateApplied DNA Sciences RevenueApplied DNA Sciences EBITApplied DNA Sciences Net Income
2025e6.53 M undefined-13.69 M undefined-12.82 M undefined
2024e3.77 M undefined-14.58 M undefined-72.7 M undefined
202313.37 M undefined-10.95 M undefined-9.95 M undefined
202218.17 M undefined-13.97 M undefined-8.38 M undefined
20219.03 M undefined-12.29 M undefined-14.29 M undefined
20201.93 M undefined-12.54 M undefined-13.03 M undefined
20195.39 M undefined-9.13 M undefined-8.93 M undefined
20183.9 M undefined-11.65 M undefined-11.69 M undefined
20174.75 M undefined-12.82 M undefined-12.86 M undefined
20164.19 M undefined-12.2 M undefined-12.18 M undefined
20159.01 M undefined-7.85 M undefined-11.88 M undefined
20142.72 M undefined-12.27 M undefined-13.07 M undefined
20132.04 M undefined-10.18 M undefined-17.69 M undefined
20121.86 M undefined-6.51 M undefined-7.15 M undefined
2011969,000 undefined-8.06 M undefined-10.52 M undefined
2010520,000 undefined-7.12 M undefined-7.91 M undefined
2009295,000 undefined-6.9 M undefined3.95 M undefined
2008873,000 undefined-4.16 M undefined-6.8 M undefined
2007122,000 undefined-12.54 M undefined-13.31 M undefined
200619,000 undefined-10.05 M undefined-2.41 M undefined
20050 undefined-51.71 M undefined-67.11 M undefined
20040 undefined-17.58 M undefined-19.36 M undefined

Applied DNA Sciences Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (k)DOCUMENTS
200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e
000000001229443519181336
---------100.00-350.00-55.56--25.0066.67-80.00800.00100.00-27.78-76.92100.00
------------75.0075.0066.6780.00100.0044.4427.7838.46--
0000000000003324145500
-17-51-10-12-4-6-7-8-6-10-12-7-12-12-11-9-12-12-13-10-14-13
---------600.00-500.00-600.00-77.78-300.00-300.00-366.67-180.00-1,200.00-133.33-72.22-76.92-466.67-216.67
-19-67-2-13-63-7-10-7-17-13-11-12-12-11-8-13-14-8-9-72-12
-252.63-97.01550.00-53.85-150.00-333.3342.86-30.00142.86-23.53-15.389.09--8.33-27.2762.507.69-42.8612.50700.00-83.33
01234668121517243033374619634644865400
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The Applied DNA Sciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Applied DNA Sciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (k)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
                                       
00.031.230.030.140.210.022.750.736.361.397.314.482.961.660.567.796.5615.227.15
00.010.0100.080.050.060.210.30.670.843.936.382.591.490.840.192.83.070.26
00800000000000000000
0000000000000.30.330.220.140.51.370.60.33
000.110.50.080.080.160.080.080.170.140.290.20.370.640.610.60.571.060.39
00.041.350.530.290.340.243.031.17.212.3611.5411.356.2442.159.0811.319.948.13
0.030.010.160.110.060.0100.090.210.70.580.570.790.520.420.231.283.022.222.08
00000000000000000000
000000000001.51.540000000
0.039.122.111.741.3710.640.2700.420.331.61.531.040.860.740.61002.7
00000000000285285285285285285000
0.020.011.060.040.120.160.530.110.040.050.240.060.080.060.060.170.10.10.10.75
0.089.143.331.891.551.171.170.470.251.171.144.024.211.911.631.422.263.122.325.53
0.089.184.682.411.851.511.413.51.358.383.5115.5515.578.155.633.5711.3414.4222.2713.65
                                       
11.990.110.120.180.210.280.350.470.650.790.010.020.020.030.0300.010.010.010.01
6.1282.3482.63128.45133.13141.41149.4160.39169.12190.52198.28224.19234.16243.5249.09255.96275.55295.23305.4307.39
-22.82-89.93-92.34-140.57-147.38-143.43-151.34-161.86-169.01-186.69-199.76-211.64-223.82-236.67-248.37-256.81-269.84-284.12-292.5-302.45
00000000000000000000
00000000000000000000
-4.71-7.47-9.59-11.94-14.04-1.75-1.6-0.990.764.62-1.4712.5710.376.860.75-0.845.7211.1112.914.95
1.880.350.341.230.410.590.720.170.470.641.061.241.530.380.51.151.252.011.741.07
0.122.225.2311.9812.410.250.250.60.120.330.441.150.720.560.460.450.680.981.881.7
0000.4000.05000.150.580.281.840.351.860.640.510.280.560.08
1.160.410.4100000000000000000
1.6303.760.743.062.411.773.73001.8000001.83000
4.792.989.7314.3615.883.252.794.50.591.123.882.674.091.32.822.254.273.274.192.85
004.530000.2200000001.591.550.52000
0000000000000000000684
013.6700000002.641.10.321.1200.470.620.850.035.175.25
013.674.530000.22002.641.10.321.1202.062.171.370.035.175.93
4.7916.6514.2614.3615.883.253.014.50.593.764.972.995.21.34.884.415.633.39.368.78
0.089.184.682.411.851.511.413.51.358.383.5115.5615.578.155.633.5711.3514.4222.2713.73
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Applied DNA Sciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Applied DNA Sciences's financial health and stability.

Assets

Applied DNA Sciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Applied DNA Sciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Applied DNA Sciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Applied DNA Sciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
-19-67-2-13-63-7-10-7-17-13-11-12-12-11-8-13-14-8-10
001,0000000000000000001,0001,000
00000000000000000000
10280000000-300200-302
1457-423-7462938231013-20
00000000000000000000
00000000000000000000
-3-9-2-2-2-2-2-3-3-7-8-6-9-7-6-6-11-13-8-6
000000000-10-20000-1-20-1
000000000-10-20000-1-20-1
00000000000000000000
00000000000000000000
20412221001000110-100
0900000421421576431816180
2941222621431576551914180
--------------------
00000000000000000000
001-10002-25-45-2-1-1-17-18-7
-3.12-9.14-3.06-2.26-2.95-2.47-2.46-3.85-4.12-9.09-8.74-9.11-10.69-7.63-7.19-6.93-12.2-15.94-9.47-7.36
00000000000000000000

Applied DNA Sciences stock margins

The Applied DNA Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Applied DNA Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Applied DNA Sciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Applied DNA Sciences's sales revenue. A higher gross margin percentage indicates that the Applied DNA Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Applied DNA Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Applied DNA Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Applied DNA Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Applied DNA Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Applied DNA Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Applied DNA Sciences Margin History

Applied DNA Sciences Gross marginApplied DNA Sciences Profit marginApplied DNA Sciences EBIT marginApplied DNA Sciences Profit margin
2025e41.39 %-209.48 %-196.19 %
2024e41.39 %-387.02 %-1,929.96 %
202341.39 %-81.94 %-74.41 %
202227.82 %-76.89 %-46.11 %
202154.59 %-136.17 %-158.24 %
202062.68 %-648.81 %-674.43 %
201983.71 %-169.33 %-165.76 %
201869.1 %-298.39 %-299.59 %
201777.33 %-269.84 %-270.6 %
201682.18 %-291.45 %-290.87 %
201541.39 %-87.18 %-131.88 %
201441.39 %-451.01 %-480.23 %
201341.39 %-499.8 %-868.66 %
201241.39 %-350.84 %-385.5 %
201141.39 %-831.37 %-1,085.14 %
201041.39 %-1,368.65 %-1,521.15 %
200979.32 %-2,337.63 %1,337.29 %
200880.41 %-475.95 %-779.15 %
200781.15 %-10,279.51 %-10,905.74 %
200615.79 %-52,894.74 %-12,684.21 %
200541.39 %0 %0 %
200441.39 %0 %0 %

Applied DNA Sciences Stock Sales Revenue, EBIT, Earnings per Share

The Applied DNA Sciences earnings per share therefore indicates how much revenue Applied DNA Sciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Applied DNA Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Applied DNA Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Applied DNA Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Applied DNA Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Applied DNA Sciences Revenue, EBIT and net profit per share

DateApplied DNA Sciences Sales per ShareApplied DNA Sciences EBIT per shareApplied DNA Sciences Earnings per Share
2025e0.63 undefined0 undefined-1.24 undefined
2024e0.37 undefined0 undefined-7.06 undefined
202320.44 undefined-16.75 undefined-15.21 undefined
202240.56 undefined-31.18 undefined-18.7 undefined
202126.09 undefined-35.53 undefined-41.29 undefined
20209.86 undefined-63.95 undefined-66.48 undefined
2019117.15 undefined-198.37 undefined-194.2 undefined
2018105.49 undefined-314.76 undefined-316.03 undefined
2017143.97 undefined-388.48 undefined-389.58 undefined
2016139.53 undefined-406.67 undefined-405.87 undefined
2015375.38 undefined-327.25 undefined-495.04 undefined
2014160.06 undefined-721.88 undefined-768.65 undefined
2013135.73 undefined-678.4 undefined-1,179.07 undefined
2012154.58 undefined-542.33 undefined-595.92 undefined
2011121.12 undefined-1,007 undefined-1,314.38 undefined
201086.67 undefined-1,186.17 undefined-1,318.33 undefined
200949.17 undefined-1,149.33 undefined657.5 undefined
2008218.25 undefined-1,038.75 undefined-1,700.5 undefined
200740.67 undefined-4,180.33 undefined-4,435 undefined
20069.5 undefined-5,025 undefined-1,205 undefined
20050 undefined-51,709 undefined-67,110 undefined
20040 undefined0 undefined0 undefined

Applied DNA Sciences business model

Applied DNA Sciences Inc (APDN) is a US-based company specializing in the development and application of DNA-based technologies. It was founded in 1983 as Identafix Inc., a biometric identification company. In 2002, the focus shifted to DNA technology and the name was changed to Applied DNA Sciences Inc. APDN's business model includes the development, manufacturing, and marketing of DNA technologies for various applications. The company's main segments are security, textiles, and agriculture. In all areas, APDN utilizes its proprietary DNA technology for authentication, testing, monitoring, and traceability. In the security industry, APDN offers a wide range of anti-counterfeiting and authentication solutions. For example, DNA technology can be used to secure identity documents such as passports and driver's licenses. The company has also partnered with the National Football League (NFL) to combat counterfeit merchandise by tagging all items with DNA tags that can be authenticated. In the textiles sector, APDN uses its DNA technology to ensure traceability of cotton and other materials. The company has partnered with various stakeholders in the fashion and retail industry. APDN has developed a comprehensive cotton traceability system that allows customers to trace the entire supply chain of their products. This helps ensure that customers receive products from sustainable production. Agriculture is another important area for APDN. The company utilizes its DNA technology for food traceability. APDN has partnered with a leading food packaging manufacturer to integrate the APDN food traceability system into the packaging. This allows customers to determine the exact origin of their food and ensure that the products come from a safe, trusted source. One of APDN's most well-known applications of DNA technology is the SigNature DNA system. This system uses DNA markers to tag and authenticate products. The SigNature DNA system can be used in a variety of industries, including textiles, agriculture, security, art, and luxury goods. But DNA technology by APDN is also significant in other areas. For example, it can be used in forensics to verify the authenticity of evidence. In medicine, DNA technology can be used to analyze patient DNA sequences and develop personalized medicines. Overall, Applied DNA Sciences Inc has become a significant provider of DNA technologies. The company is active in various industries and offers a wide range of solutions. APDN's DNA technology has the potential to change the way we mark and identify products. Applied DNA Sciences is one of the most popular companies on Eulerpool.com.

Applied DNA Sciences SWOT Analysis

Strengths

Applied DNA Sciences Inc has a strong track record in developing innovative DNA-based authentication solutions.

The company has established a robust intellectual property portfolio, providing a competitive advantage in the market.

Applied DNA Sciences Inc has cultivated strategic partnerships with various industry leaders, enhancing its market presence and opportunities for collaboration.

Weaknesses

The company heavily relies on the success of its research and development efforts, making it vulnerable to potential setbacks or delays.

Applied DNA Sciences Inc may face challenges in scaling up its production capabilities to meet growing demand.

The company's products and solutions are subject to regulatory and legal requirements, which could pose compliance risks.

Opportunities

The increasing need for secure and reliable authentication technologies presents significant market opportunities for Applied DNA Sciences Inc.

Growing awareness about the importance of counterfeit prevention and supply chain integrity creates a favorable market environment for the company.

Applied DNA Sciences Inc can explore expansion into new geographic markets or industries to diversify its revenue streams.

Threats

The competitive landscape in the DNA authentication industry is rapidly evolving, which could intensify competition and impact market share.

Economic downturns or market fluctuations may affect customer spending patterns and reduce demand for the company's solutions.

Changes in regulations or legal frameworks related to authentication technologies could pose challenges and require costly adaptations.

Applied DNA Sciences Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Applied DNA Sciences historical P/E ratio, EBIT, and P/S ratio.

Applied DNA Sciences shares outstanding

The number of shares was Applied DNA Sciences in 2023 — This indicates how many shares 654,000 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Applied DNA Sciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Applied DNA Sciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Applied DNA Sciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Applied DNA Sciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Applied DNA Sciences Stock splits

In Applied DNA Sciences's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Applied DNA Sciences.

Applied DNA Sciences latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.36 0.47  (231.65 %)2024 Q3
3/31/2024-4.59 -5.31  (-15.69 %)2024 Q2
12/31/2023-6.32 -1.8  (71.54 %)2024 Q1
9/30/2023-5.51 -5.2  (5.59 %)2023 Q4
6/30/2023-0.24 -0.24  (1.96 %)2023 Q3
3/31/2023-0.2 0.05  (124.51 %)2023 Q2
12/31/2022-0.3 -0.3  (-1.42 %)2023 Q1
9/30/2022-0.27 -0.01  (96.23 %)2022 Q4
6/30/2022-0.36 -0.13  (64.1 %)2022 Q3
3/31/2022-0.34 -0.23  (32.35 %)2022 Q2
1
2
3
4
...
5

Applied DNA Sciences list of shareholders

%
Name
Stocks
Change
Date
5.08 % The Vanguard Group, Inc.523,691012/31/2023
3.59 % AMH Equity, Ltd.370,000-217,23212/31/2023
16.18 % Grossman (Bruce)1,666,7981,666,7982/2/2024
15.17 % Armistice Capital LLC1,561,9951,561,9953/12/2024
1.35 % Geode Capital Management, L.L.C.139,187012/31/2023
1.30 % Hayward (James A)134,18603/12/2024
0.99 % Murrah (Judith)101,8537,6393/12/2024
0.98 % BlackRock Institutional Trust Company, N.A.101,295-36612/31/2023
0.95 % Concept Asset Management98,30106/30/2023
0.95 % Silverberg Bernstein Capital Management, LLC98,30103/31/2024
1
2
3
4
5
...
7

Applied DNA Sciences Executives and Management Board

Dr. James Hayward70
Applied DNA Sciences Chairman of the Board, President, Chief Executive Officer
Compensation 2.07 M
Ms. Judith Murrah65
Applied DNA Sciences Chief Operating Officer, Chief Information Officer, Secretary
Compensation 586,625
Ms. Beth Jantzen46
Applied DNA Sciences Chief Financial Officer
Compensation 526,500
Dr. Yacov Shamash73
Applied DNA Sciences Independent Director
Compensation 160,000
Mr. Joseph Ceccoli60
Applied DNA Sciences Independent Director
Compensation 155,000
1
2

Applied DNA Sciences Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Himatsingka Seide Stock
Himatsingka Seide
SupplierCustomer0,880,910,840,760,51-0,49
Eurofins Scientific Stock
Eurofins Scientific
SupplierCustomer0,750,87-0,310,780,58-0,48
Danaher Stock
Danaher
SupplierCustomer0,590,850,220,810,28-0,60
Reliance Industries Stock
Reliance Industries
SupplierCustomer-0,15-0,79-0,73-0,40-0,55-0,67
Flora Growth Stock
Flora Growth
SupplierCustomer-0,150,700,520,400,58-
Cie Financiere Richemont Stock
Cie Financiere Richemont
SupplierCustomer-0,320,580,710,87-0,20-0,69
Tyme Technologies Stock
Tyme Technologies
SupplierCustomer-0,50-0,11-0,090,930,910,81
TruTrace Technologies Stock
TruTrace Technologies
SupplierCustomer-0,85-0,79-0,81-0,85-0,65-0,41
GHCL Stock
GHCL
SupplierCustomer-0,89-0,89-0,75-0,78-0,79-0,82
1

Most common questions regarding Applied DNA Sciences

What values and corporate philosophy does Applied DNA Sciences represent?

Applied DNA Sciences Inc represents a set of core values and a corporate philosophy that emphasizes innovation, integrity, and sustainability. With a focus on creating DNA-based solutions, the company is committed to advancing technology for authentication, supply chain security, and anti-counterfeiting measures. Applied DNA Sciences Inc aims to provide industries with reliable, traceable, and secure solutions that protect products, brands, and intellectual property. By incorporating DNA technologies into various sectors, the company strives to promote transparency, ethical practices, and sustainability. Applied DNA Sciences Inc's dedication to scientific excellence and its global partnerships allows it to deliver cutting-edge solutions tailored to meet the unique needs of its customers in different industries.

In which countries and regions is Applied DNA Sciences primarily present?

Applied DNA Sciences Inc is primarily present in the United States. As a leading provider of DNA-based authentication solutions, Applied DNA Sciences Inc operates across various industries, including textiles, pharmaceuticals, and cannabis. With its headquarters in Stony Brook, New York, the company serves clients both domestically and internationally. While its presence expands across the globe, Applied DNA Sciences Inc focuses primarily on the United States market, where it leverages its innovative technologies to combat counterfeiting and enhance supply chain security.

What significant milestones has the company Applied DNA Sciences achieved?

Applied DNA Sciences Inc has achieved several significant milestones. One notable achievement was the successful completion of a collaboration with TheraCann International involving the integration of DNA technology into the global cannabis supply chain. The company has also made advancements in securing global supply chains, providing solutions to combat counterfeit products, protect valuable assets, and prevent theft. Applied DNA Sciences Inc has expanded its scope by collaborating with various sectors including textiles, pharmaceuticals, and defense. Moreover, the company has received multiple awards and recognition for its innovative anti-counterfeiting technology. Overall, Applied DNA Sciences Inc continues to make strides in enabling secure, traceable, and transparent supply chains across industries.

What is the history and background of the company Applied DNA Sciences?

Applied DNA Sciences Inc is a leading provider of DNA-based technology solutions for supply chain security, anti-counterfeiting, and anti-theft applications. Established in 1983, Applied DNA Sciences Inc has a rich history in developing innovative DNA-based authentication and security solutions. The company utilizes its proprietary SigNature DNA platform to create unique DNA markers that can be applied to a wide range of products. These markers can be used to verify the authenticity and origin of products, ensuring supply chain integrity and protecting against counterfeiting. Applied DNA Sciences Inc has a strong track record of working with various industries, including textiles, pharmaceuticals, and electronics, providing them with robust solutions to combat illicit activities.

Who are the main competitors of Applied DNA Sciences in the market?

The main competitors of Applied DNA Sciences Inc in the market are Thermo Fisher Scientific Inc, Illumina Inc, and Eurofins Scientific SE.

In which industries is Applied DNA Sciences primarily active?

Applied DNA Sciences Inc is primarily active in the industries of textile manufacturing, supply chain security, and anti-counterfeiting.

What is the business model of Applied DNA Sciences?

The business model of Applied DNA Sciences Inc involves providing molecular-based security and authentication solutions to industries including textiles, pharmaceuticals, automotive, electronics, and more. The company utilizes DNA-based tagging and authentication technologies to ensure the integrity and traceability of products, as well as to combat counterfeiting and fraud. Applied DNA Sciences offers a range of innovative solutions such as DNA marking, DNA authentication, and supply chain traceability. By leveraging its expertise in DNA-based technology, the company aims to protect brands, increase transparency in supply chains, and provide assurance to consumers that the products they purchase are genuine and safe.

What is the P/E ratio of Applied DNA Sciences 2024?

The Applied DNA Sciences P/E ratio is -0.01.

What is the P/S ratio of Applied DNA Sciences 2024?

The Applied DNA Sciences P/S ratio is 0.25.

What is the AlleAktien quality score of Applied DNA Sciences?

The AlleAktien quality score for Applied DNA Sciences is 4/10.

What is the revenue of Applied DNA Sciences 2024?

The expected Applied DNA Sciences revenue is 3.77 M USD.

How high is the profit of Applied DNA Sciences 2024?

The expected Applied DNA Sciences profit is -72.7 M USD.

What is the business model of Applied DNA Sciences

Applied DNA Sciences Inc is a company that specializes in the development and application of DNA technologies. Its business model is based on providing customized DNA solutions to customers in various industries. One of the main divisions of Applied DNA Sciences is DNA-based authentication technology. Customers in textiles, security, pharmaceuticals, and agriculture can use this technology to secure products, processes, or supply chains. By marking products or packaging with a "DNA tag," customers can verify the authenticity of the products and prevent counterfeiting or fraud. This technology is also used in the pharmaceutical industry to combat counterfeit drugs and ensure patient safety. Another division of Applied DNA Sciences is DNA technology for the identification of individuals and animals. This includes DNA identification of animals in agriculture and pets, as well as the identification of individuals to prevent identity theft. This technology can also be used in forensics to convict criminals and identify victims. Another business field of Applied DNA Sciences is DNA-based anti-counterfeiting technology to prevent product counterfeiting. This technology can be used in various industries, such as combating counterfeit luxury goods and counterfeit auto parts in the automotive industry. Applied DNA Sciences Inc also offers DNA products, including the Synthetic DNA Armed Forces Platform (SigNature® DNA) and the molecular tagging system (taggants). SigNature DNA is a unique DNA signature system designed to protect products and identify criminals, while taggants were specifically developed for the Authentic-Secure series of security labels. In addition to these divisions, Applied DNA Sciences also develops advanced DNA methods and technologies for the detection of biological threats. These technologies have been developed to respond to biological threats such as viruses and bacteria and can be used in various applications, including healthcare, food safety, and environmental monitoring. In conclusion, Applied DNA Sciences Inc is a company with a wide portfolio of DNA-based solutions. The company offers various technologies to help customers in different industries secure their products, supply chains, and processes. The wide range of solutions allows Applied DNA Sciences to position itself in various industries and establish itself as a key player in the DNA industry.

What is the Applied DNA Sciences dividend?

Applied DNA Sciences pays a dividend of 0 USD distributed over payouts per year.

How often does Applied DNA Sciences pay dividends?

The dividend cannot currently be calculated for Applied DNA Sciences or the company does not pay out a dividend.

What is the Applied DNA Sciences ISIN?

The ISIN of Applied DNA Sciences is US03815U3005.

What is the Applied DNA Sciences WKN?

The WKN of Applied DNA Sciences is A2PUTA.

What is the Applied DNA Sciences ticker?

The ticker of Applied DNA Sciences is APDN.

How much dividend does Applied DNA Sciences pay?

Over the past 12 months, Applied DNA Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Applied DNA Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Applied DNA Sciences?

The current dividend yield of Applied DNA Sciences is .

When does Applied DNA Sciences pay dividends?

Applied DNA Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Applied DNA Sciences?

Applied DNA Sciences paid dividends every year for the past 0 years.

What is the dividend of Applied DNA Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Applied DNA Sciences located?

Applied DNA Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Applied DNA Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Applied DNA Sciences from 9/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/7/2024.

When did Applied DNA Sciences pay the last dividend?

The last dividend was paid out on 9/7/2024.

What was the dividend of Applied DNA Sciences in the year 2023?

In the year 2023, Applied DNA Sciences distributed 0 USD as dividends.

In which currency does Applied DNA Sciences pay out the dividend?

The dividends of Applied DNA Sciences are distributed in USD.

All fundamentals about Applied DNA Sciences

Our stock analysis for Applied DNA Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Applied DNA Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.